Acute Bacterial Skin And Skin Structure Infection Market
Acute Bacterial Skin & Skin Structure Infection Market Forecasts to 2030 - Global Analysis By Infection Type (Community-Acquired, Hospital-Acquired and Other Infection Types), Diagnostic Type, Treatment, Route of Administration, Distribution Channel, and By Geography
According to Stratistics MRC, the Global Acute Bacterial Skin & Skin Structure Infection Market is accounted for $11,708.32 million in 2023 and is expected to reach $25,243.1 million by 2030 growing at a CAGR of 11.6% during the forecast period. Acute Bacterial Skin and Skin Structure Infection (ABSSSI) refers to a range of bacterial infections affecting the skin and underlying tissues, commonly caused by Staphylococcus aureus and Streptococcus pyogenes. These infections manifest with symptoms like redness, warmth, swelling, and pain at the site of infection. ABSSSIs can range from mild cellulitis to more severe conditions like abscesses or wound infections. Prompt diagnosis and treatment are crucial to prevent complications and promote healing in ABSSSI cases.
According to a study published in the International Journal of Antimicrobial Agents in August 2022, almost 10% of all hospital admissions in the United States and around 15% of all infections treated in European hospitals are due to ABSSSIs.
Market Dynamics:
Driver:
Increasing healthcare expenditure
Rising healthcare expenditures foster research and development efforts aimed at developing innovative therapies and diagnostic tools for ABSSSI. With higher healthcare budgets, healthcare systems can afford to implement advanced diagnostic techniques, such as molecular testing and point-of-care testing. Additionally, increased expenditure allows for the development and adoption of novel therapies targeting antibiotic-resistant bacteria, which is propelling this market further.
Restraint:
Inadequate healthcare infrastructure
Limited healthcare facilities and resources can lead to overcrowding in hospitals and clinics, further exacerbating the strain on the healthcare system and decreasing the delivery of quality care. Without proper facilities for wound care, sterile procedures, and antibiotic administration, managing ABSSSI cases becomes more challenging and may increase the risk of complications and treatment failures. Moreover, inadequate healthcare infrastructure can hinder this market further.
Opportunity:
Advancements in diagnostics
Technological innovations have revolutionized the field of infectious disease diagnosis, enabling faster, more accurate, and more efficient identification of causative pathogens. These advancements in diagnostics not only improve patient outcomes by enabling early and accurate diagnosis of ABSSSI but also contribute to antimicrobial stewardship efforts by optimizing antibiotic use and reducing the risk of antibiotic resistance, which gradually boosts this market growth.
Threat:
Limited awareness and diagnosis
A lack of awareness among both healthcare providers and patients about ABSSSI symptoms, risk factors, and appropriate management strategies leads to delays in seeking medical care, misdiagnosis, or inappropriate use of antibiotics. Moreover, limited awareness of ABSSSI among healthcare providers may contribute to diagnostic errors; as a consequence, patients may experience complications, disease progression, and increased healthcare costs, thereby hampering this market expansion.
Covid-19 Impact
The COVID-19 pandemic has had several negative impacts on the Acute Bacterial Skin and Skin Structure Infection (ABSSSI) market. During the pandemic, healthcare resources were diverted towards managing COVID-19 patients, leading to delays in non-emergency procedures, elective surgeries, and routine medical visits. Furthermore, the economic repercussions of the pandemic, including job losses, reduced healthcare budgets, and supply chain disruptions, have created financial constraints for patients and healthcare systems, which hindered this market.
The hospital-acquired segment is expected to be the largest during the forecast period
The hospital-acquired segment is estimated to hold the largest share. It refers to infections that patients acquire during their hospital stay or healthcare facility visit. Hospital-acquired ABSSSI often involves a broader spectrum of bacteria compared to community-acquired infections. Additionally, healthcare providers must carefully consider the choice of antibiotics and may resort to broad-spectrum agents or combination therapy to effectively treat these infections, which significantly boosts this segment’s expansion.
The gram staining segment is expected to have the highest CAGR during the forecast period
The gram staining segment is anticipated to have highest CAGR during the forecast period due to the fact that it is a diagnostic technique used to categorize bacteria based on their cell wall composition. Gram staining involves the application of crystal violet and iodine, which differentiates bacteria into two main groups: gram-positive and gram-negative. Moreover, advancements in Gram staining techniques, such as rapid automated systems and point-of-care testing devices, are driving growth within this segment.
Region with largest share:
Asia Pacific commanded the largest market share during the extrapolated period owing to a diverse healthcare landscape and varying patterns of infection prevalence across countries. The region's robust healthcare infrastructure and emphasis on evidence-based medicine drive demand for innovative treatments and diagnostic solutions for ABSSSI. Furthermore, collaborations between stakeholders drive innovation, clinical research, and the adoption of advanced diagnostic technologies, thereby driving this region's expansion.
Region with highest CAGR:
Europe is expected to witness highest CAGR over the projection period, owing to an increased focus on improving diagnostic capabilities, enhancing infection prevention measures, and developing novel therapeutics to address the rising incidence of ABSSSI. This region is home to some of the major players, such as Melinta Therapeutics, Inc., Melinta Therapeutics, Inc., and Pfizer, Inc. Therefore, it presents significant opportunities for companies to innovate, expand their product offerings, contribute to improving patient outcomes, and drive the region's growth.
Key players in the market
Some of the key players in the Acute Bacterial Skin & Skin Structure Infection Market include Paratek Pharmaceuticals, Inc., Merck & Co., Inc., Cumberland Pharmaceuticals Inc., Allergan, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Melinta Therapeutics, Inc., Glenmark Pharmaceuticals Ltd, Endo Pharmaceuticals Inc., Nabriva Therapeutics PLC, Basilea Pharmaceutica Ltd, Melinta Therapeutics, Inc., Menarini Group and Sandoz Inc.
Key Developments:
In January 2024, Glenmark Pharmaceuticals Ltd. announced the launch of their alliance – Ichnos Glenmark Innovation – to accelerate new drug discovery in cancer treatment.
In December 2023, Pfizer Inc. announced topline data from the Phase 2b clinical trial investigating its oral Glucagon-like peptide-1 receptor agonist candidate, danuglipron, in adults with obesity and without type 2 diabetes.
In September 2023, Glenmark Pharmaceuticals Limited has entered into a definitive agreement with Nirma Limited to divest 75% stake in its subsidiary, Glenmark Life Sciences Limited (""GLS""), for an aggregate consideration, subject to closing adjustments.
Infection Types Covered:
• Community-Acquired
• Hospital-Acquired
• Other Infection Types
Diagnostic Types Covered:
• Clinical Diagnosis
• Gram Staining
• Blood Tests
• Biomarker Assays
• Molecular Diagnostics
• Microbiological Cultures
• Other Diagnostic Types
Treatments Covered:
• Tedizolid
• Delafloxacin
• Daptomycin
• Vancomycin
• Tigecycline
• Ceftaroline fosamil
• Linezolid
• Oritavancin
• Other Treatments
Route of Administration Covered:
• Parenteral
• Topical
• Oral
Distribution Channels Covered:
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Other Distribution Channels
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Acute Bacterial Skin & Skin Structure Infection Market, By Infection Type
5.1 Introduction
5.2 Community-Acquired
5.3 Hospital-Acquired
5.4 Other Infection Types
6 Global Acute Bacterial Skin & Skin Structure Infection Market, By Diagnostic Type
6.1 Introduction
6.2 Clinical Diagnosis
6.3 Gram Staining
6.4 Blood Tests
6.5 Biomarker Assays
6.6 Molecular Diagnostics
6.7 Microbiological Cultures
6.8 Other Diagnostic Types
7 Global Acute Bacterial Skin & Skin Structure Infection Market, By Treatment
7.1 Introduction
7.2 Tedizolid
7.3 Delafloxacin
7.4 Daptomycin
7.5 Vancomycin
7.6 Tigecycline
7.7 Ceftaroline fosamil
7.8 Linezolid
7.9 Oritavancin
7.10 Other Treatments
8 Global Acute Bacterial Skin & Skin Structure Infection Market, By Route of Administration
8.1 Introduction
8.2 Parenteral
8.3 Topical
8.4 Oral
9 Global Acute Bacterial Skin & Skin Structure Infection Market, By Distribution Channel
9.1 Introduction
9.2 Retail Pharmacies
9.3 Hospital Pharmacies
9.4 Online Pharmacies
9.5 Other Distribution Channels
10 Global Acute Bacterial Skin & Skin Structure Infection Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Paratek Pharmaceuticals, Inc.
12.2 Merck & Co., Inc.
12.3 Cumberland Pharmaceuticals Inc.
12.4 Allergan
12.5 Pfizer Inc.
12.6 Teva Pharmaceutical Industries Ltd.
12.7 Melinta Therapeutics, Inc.
12.8 Glenmark Pharmaceuticals Ltd
12.9 Endo Pharmaceuticals Inc.
12.10 Nabriva Therapeutics PLC
12.11 Basilea Pharmaceutica Ltd
12.12 Cipher Pharmaceuticals
12.13 Menarini Group
12.14 Sandoz Inc.
List of Tables
1 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Region (2021-2030) ($MN)
2 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Infection Type (2021-2030) ($MN)
3 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Community-Acquired (2021-2030) ($MN)
4 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Hospital-Acquired (2021-2030) ($MN)
5 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Other Infection Types (2021-2030) ($MN)
6 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Diagnostic Type (2021-2030) ($MN)
7 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Clinical Diagnosis (2021-2030) ($MN)
8 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Gram Staining (2021-2030) ($MN)
9 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Blood Tests (2021-2030) ($MN)
10 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Biomarker Assays (2021-2030) ($MN)
10 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Molecular Diagnostics (2021-2030) ($MN)
11 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Microbiological Cultures (2021-2030) ($MN)
12 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Other Diagnostic Types (2021-2030) ($MN)
14 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Treatment (2021-2030) ($MN)
15 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Tedizolid (2021-2030) ($MN)
16 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Delafloxacin (2021-2030) ($MN)
17 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Daptomycin (2021-2030) ($MN)
18 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Vancomycin (2021-2030) ($MN)
19 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Tigecycline (2021-2030) ($MN)
20 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Ceftaroline fosamil (2021-2030) ($MN)
21 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Linezolid (2021-2030) ($MN)
22 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Oritavancin (2021-2030) ($MN)
23 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Other Treatments (2021-2030) ($MN)
24 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Route of Administration (2021-2030) ($MN)
25 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Parenteral (2021-2030) ($MN)
26 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Topical (2021-2030) ($MN)
27 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Oral (2021-2030) ($MN)
28 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Distribution Channel (2021-2030) ($MN)
29 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
30 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
31 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Online Pharmacies (2021-2030) ($MN)
32 Global Acute Bacterial Skin & Skin Structure Infection Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
